Erratum: Rodriguez et al. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers 2021, 13, 3871.
Emma RodriguezGuangsheng PeiZhong-Ming ZhaoSang T KimAlexis GermanPrema RobinsonPublished in: Cancers (2021)
One contributor's name was missing in the original version of the authorship of the paper [...].